Cargando…

Local production of pharmaceuticals in Africa and access to essential medicines: 'urban bias’ in access to imported medicines in Tanzania and its policy implications

BACKGROUND: International policy towards access to essential medicines in Africa has focused until recently on international procurement of large volumes of medicines, mainly from Indian manufacturers, and their import and distribution. This emphasis is now being challenged by renewed policy interes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mujinja, Phares GM, Mackintosh, Maureen, Justin-Temu, Mary, Wuyts, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021829/ https://www.ncbi.nlm.nih.gov/pubmed/24612518 http://dx.doi.org/10.1186/1744-8603-10-12

Ejemplares similares

Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
por: Mackintosh, Maureen, et al.
Publicado: (2011)

Is the Brazilian pharmaceutical policy ensuring population access to essential medicines?
por: Bertoldi, Andréa Dâmaso, et al.
Publicado: (2012)

Traditional and Complementary Medicine in Tanzania: Regulation Awareness, Adherence and Challenges
por: Mujinja, Phares Gamba, et al.
Publicado: (2021)

Patients’ pathways to cancer care in Tanzania: documenting and addressing social inequalities in reaching a cancer diagnosis
por: Makene, Fortunata Songora, et al.
Publicado: (2022)

Household perceptions towards a redistributive policy across health insurance funds in Tanzania
por: Chomi, Eunice N, et al.
Publicado: (2015)

Access to Medicines and Pharmaceutical Policy in Saudi Arabia: A Scoping Review
por: Mirza, Ahmer Hameed, et al.
Publicado: (2023)

Equity implications of coverage and use of insecticide treated nets distributed for free or with co-payment in two districts in Tanzania: A cross-sectional comparative household survey
por: Ruhago, George M, et al.
Publicado: (2011)

Trends and Challenges in Access to Essential Medicines in Ethiopia and the Contributions of Local Pharmaceutical Production
por: Marew, Tesfa, et al.
Publicado: (2022)

Access to medicines: relations with the institutionalization of pharmaceutical services
por: de Barros, Rafael Damasceno, et al.
Publicado: (2017)

Access to Essential Medicines in Pakistan: Policy and Health Systems Research Concerns
por: Zaidi, Shehla, et al.
Publicado: (2013)

Health Related Quality of Life Post Labour Induction with Misoprostol Versus Dinoprostone At Muhimbili National Hospital in Dar Es Salaam, Tanzania: A cross Sectional Study
por: Kagwisage, Jonas, et al.
Publicado: (2020)

Global Pharmaceutical Manufacturing: Association for Accessible Medicines Perspective
por: Gaugh, David
Publicado: (2020)

From papers to practices: district level priority setting processes and criteria for family planning, maternal, newborn and child health interventions in Tanzania
por: Chitama, Dereck, et al.
Publicado: (2011)

A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia
por: Coghlan, Renia, et al.
Publicado: (2018)

Public policy coverage and access to medicines in Brazil
por: de Moraes, Ricardo Montes, et al.
Publicado: (2022)

The future of medicines use and access research: using the Journal of Pharmaceutical Policy and Practice as a platform for change
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2014)

Access to hepatitis C medicines
por: Edwards, Danny J, et al.
Publicado: (2015)

Pharmaceutical Strategic Purchasing: a Key to Improve Access to Medicines
por: Mehralian, Gholamhossein, et al.
Publicado: (2015)

Patent pooling to increase access to essential medicines
por: Burrone, Esteban, et al.
Publicado: (2019)

Access and use of WHO essential medicines in Italy
por: Petrella, Alessandro, et al.
Publicado: (2023)

Access to Medicines, Access to Markets
por: Sismondo, Sergio
Publicado: (2020)

Challenges of access to medicine and the responsibility of pharmaceutical companies: a legal perspective
por: Ahmadiani, Saeed, et al.
Publicado: (2016)

Perspectives of pharmaceutical stakeholders on determinants of medicines accessibility at the primary care level
por: Rizk, Hoda Ibrahim, et al.
Publicado: (2021)

Deconstructing and Historicizing Access to Medicines: The Changing Priority of Pharmaceutical Governance in China
por: Li, Lantian
Publicado: (2021)

Access to essential medicines and standard treatment for chronic diseases
por: Kotwani, Anita
Publicado: (2010)

Determinants of delay in care seeking among children under five with fever in Dodoma region, central Tanzania: a cross-sectional study
por: Kassile, Telemu, et al.
Publicado: (2014)

Risk distribution across multiple health insurance funds in rural Tanzania
por: Chomi, Eunice Nahyuha, et al.
Publicado: (2014)

Access to HIV prevention services among gender based violence survivors in Tanzania
por: Mboya, Beati, et al.
Publicado: (2012)

Understanding how domestic health policy is integrated into foreign policy in South Africa: a case for accelerating access to antiretroviral medicines
por: Modisenyane, Simon Moeketsi, et al.
Publicado: (2017)

Human resources health supply chains and access to essential medicines
por: Brown, Andrew, et al.
Publicado: (2014)

Threat of compulsory licences could increase access to essential medicines
por: Ooms, Gorik, et al.
Publicado: (2019)

Noncommunicable diseases, access to essential medicines and universal health coverage
por: Beran, David, et al.
Publicado: (2019)

Accessibility of essential anticancer medicines for children in the Sichuan Province of China
por: Chen, Zhe, et al.
Publicado: (2022)

How to assure access of essential RMNCH medicines by looking at policy and systems factors: an analysis of countdown to 2015 countries
por: Briggs, Jane, et al.
Publicado: (2018)

Universal access to essential medicines as part of the right to health: a cross-national comparison of national laws, medicines policies, and health system indicators
por: Perehudoff, Katrina
Publicado: (2020)

TRIPS, the Doha Declaration and increasing access to medicines: policy options for Ghana
por: Cohen, JC, et al.
Publicado: (2005)

How Drug Control Policy and Practice Undermine Access to Controlled Medicines
por: Burke-Shyne, Naomi, et al.
Publicado: (2017)

Pharmaceutics: A New Open-Access Journal for All Those Interested in Designing Medicines
por: Perrie, Yvonne, et al.
Publicado: (2009)

Antibiotic geographies and access to medicines: Tracing the role of India's pharmaceutical industry in global trade
por: Bjerke, Lise
Publicado: (2022)

The access paradox: abortion law, policy and practice in Ethiopia, Tanzania and Zambia
por: Blystad, Astrid, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1et99j5qjnvbl823liduu6m8vn